Previous studies showed that increased GRK2 levels were found in mononuclear cells in patients with metabolic syndrome while Tamoxifen triggered GRK2 deletion in mice leads to reversal of insulin resistance, improve fasting and impaired glucose tolerance [13]. The gene discussed is GRK2; the disease is Insulin resistance.